Interestingly, it has been reported that the combination of Aβ42 and tau or ptau as a ratio provides the best discriminative value to date for AD cases [35], [36] and predict the conversion from non-dementia clinical status to dementia [37]. This evidence concerns the gene MAPT and Alzheimer disease.